DE102016203696A1 - Ophthalmologische Zusammensetzung - Google Patents
Ophthalmologische Zusammensetzung Download PDFInfo
- Publication number
- DE102016203696A1 DE102016203696A1 DE102016203696.3A DE102016203696A DE102016203696A1 DE 102016203696 A1 DE102016203696 A1 DE 102016203696A1 DE 102016203696 A DE102016203696 A DE 102016203696A DE 102016203696 A1 DE102016203696 A1 DE 102016203696A1
- Authority
- DE
- Germany
- Prior art keywords
- ophthalmic composition
- composition according
- ectoine
- eye
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102016203696.3A DE102016203696A1 (de) | 2016-03-07 | 2016-03-07 | Ophthalmologische Zusammensetzung |
| AU2017231697A AU2017231697B2 (en) | 2016-03-07 | 2017-03-07 | Ophthalmological composition |
| ES17709641T ES2922821T3 (es) | 2016-03-07 | 2017-03-07 | Composición oftálmica |
| EP17709641.9A EP3426226B1 (de) | 2016-03-07 | 2017-03-07 | Ophthalmologische zusammensetzung |
| CA3015592A CA3015592C (en) | 2016-03-07 | 2017-03-07 | Ophthalmological composition |
| PT177096419T PT3426226T (pt) | 2016-03-07 | 2017-03-07 | Composição oftalmológica |
| RU2018130713A RU2749723C2 (ru) | 2016-03-07 | 2017-03-07 | Офтальмологическая композиция |
| KR1020187025990A KR20180117635A (ko) | 2016-03-07 | 2017-03-07 | 안과용 조성물 |
| BR112018067995-0A BR112018067995B1 (pt) | 2016-03-07 | 2017-03-07 | Composição oftalmológica |
| MX2018010788A MX382534B (es) | 2016-03-07 | 2017-03-07 | Composicion oftalmologica |
| LTEPPCT/EP2017/055338T LT3426226T (lt) | 2016-03-07 | 2017-03-07 | Oftalmologinė kompozicija |
| US16/082,791 US20190099441A1 (en) | 2016-03-07 | 2017-03-07 | Ophthalmological composition |
| PCT/EP2017/055338 WO2017153415A1 (de) | 2016-03-07 | 2017-03-07 | Ophthalmologische zusammensetzung |
| CN201780015735.3A CN108778250A (zh) | 2016-03-07 | 2017-03-07 | 眼科用组合物 |
| JP2018547451A JP2019511494A (ja) | 2016-03-07 | 2017-03-07 | 眼科用組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102016203696.3A DE102016203696A1 (de) | 2016-03-07 | 2016-03-07 | Ophthalmologische Zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102016203696A1 true DE102016203696A1 (de) | 2017-09-07 |
Family
ID=58264510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102016203696.3A Withdrawn DE102016203696A1 (de) | 2016-03-07 | 2016-03-07 | Ophthalmologische Zusammensetzung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20190099441A1 (es) |
| EP (1) | EP3426226B1 (es) |
| JP (1) | JP2019511494A (es) |
| KR (1) | KR20180117635A (es) |
| CN (1) | CN108778250A (es) |
| AU (1) | AU2017231697B2 (es) |
| BR (1) | BR112018067995B1 (es) |
| DE (1) | DE102016203696A1 (es) |
| ES (1) | ES2922821T3 (es) |
| LT (1) | LT3426226T (es) |
| MX (1) | MX382534B (es) |
| PT (1) | PT3426226T (es) |
| RU (1) | RU2749723C2 (es) |
| WO (1) | WO2017153415A1 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3426226B1 (de) | 2016-03-07 | 2022-05-04 | URSAPHARM Arzneimittel GmbH | Ophthalmologische zusammensetzung |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109771427A (zh) * | 2019-01-30 | 2019-05-21 | 上海克琴科技有限公司 | 一种通过提高依克多因光学纯度来增强其安全性和抗炎抗过敏活性的方法 |
| EP3827818A1 (en) * | 2019-11-26 | 2021-06-02 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic composition |
| CN110974830A (zh) * | 2019-12-26 | 2020-04-10 | 华熙生物科技股份有限公司 | 一种用于预防、缓解或治疗皮肤过敏的外用组合物及其用途 |
| CN111518627A (zh) * | 2020-05-09 | 2020-08-11 | 华熙生物科技股份有限公司 | 一种隐形眼镜护理液以及制备方法 |
| DE102020112603A1 (de) * | 2020-05-10 | 2021-11-11 | Bitop Aktiengesellschaft | Kompatible Solute zur Prävention oder Behandlung von SARS-CoV-2-Infektionen |
| CN111467349B (zh) * | 2020-05-14 | 2021-06-01 | 华熙生物科技股份有限公司 | 人工泪液及其制备方法 |
| CN111407774B (zh) * | 2020-05-15 | 2022-03-22 | 华熙生物科技股份有限公司 | 一种眼科用组合物及其制备方法 |
| CN111905094B (zh) * | 2020-06-15 | 2022-08-09 | 华熙生物科技股份有限公司 | 一种眼用组合物及其在制备用于干眼症的药物中的用途 |
| CN112220102B (zh) * | 2020-09-25 | 2022-12-09 | 山东华熙海御生物医药有限公司 | 一种含透明质酸和依克多因的电子烟液及其制备方法 |
| CN112480483B (zh) * | 2020-11-27 | 2022-02-01 | 华熙生物科技股份有限公司 | 一种依克多因-透明质酸复合凝胶的制备方法及所得产品 |
| CN112870455B (zh) * | 2021-02-05 | 2022-05-24 | 华熙生物科技股份有限公司 | 一种含透明质酸的凝胶制剂、制法及其在内窥镜检查中的应用 |
| US12012238B2 (en) * | 2021-05-26 | 2024-06-18 | Bausch + Lomb Ireland Limited | Packaging solutions |
| CN116139067B (zh) * | 2021-11-22 | 2024-03-22 | 华熙生物科技股份有限公司 | 透明质酸锌形成凝胶的方法及含有透明质酸锌的滴眼凝胶及其制备 |
| CN114569491B (zh) * | 2022-04-18 | 2023-08-18 | 华熙生物科技股份有限公司 | 一种抑制油脂生成的组合物及其用途 |
| CN115317598A (zh) * | 2022-09-22 | 2022-11-11 | 深圳中科欣扬生物科技有限公司 | 一种用于口腔溃疡的含sod贴剂及其制备方法 |
| CN116024050A (zh) * | 2022-12-14 | 2023-04-28 | 江苏视准医疗器械有限公司 | 一种角膜接触镜保存液组合物及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0671161B1 (de) | 1993-12-14 | 2003-10-22 | MERCK PATENT GmbH | Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten |
| EP2214658B1 (de) | 2007-10-31 | 2011-06-22 | Bitop AG | Osmolythaltige zubereitung zur anwendung bei trockenen schleimhäuten |
| DE102014007423A1 (de) * | 2014-05-22 | 2015-11-26 | Bitop Ag | Zusammensetzung zur Behandlung des Auges |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4540872B2 (ja) * | 2001-04-02 | 2010-09-08 | 株式会社資生堂 | 乾燥による皮膚傷害の抑制剤もしくは修復剤 |
| DE10161110A1 (de) * | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
| DE10161149B4 (de) * | 2001-12-12 | 2007-03-08 | Ursapharm Arzneimittel Gmbh & Co. Kg | Verwendung von Heparin-haltigem Ophthalmikum |
| US7160560B2 (en) * | 2003-10-23 | 2007-01-09 | L'oreal S.A. | Skin-care composition |
| CN101491526A (zh) * | 2009-03-03 | 2009-07-29 | 山东大学 | 四氢嘧啶在制备治疗关节炎的药物中的应用 |
| DE102016203696A1 (de) | 2016-03-07 | 2017-09-07 | Ursapharm Arzneimittel Gmbh | Ophthalmologische Zusammensetzung |
-
2016
- 2016-03-07 DE DE102016203696.3A patent/DE102016203696A1/de not_active Withdrawn
-
2017
- 2017-03-07 US US16/082,791 patent/US20190099441A1/en not_active Abandoned
- 2017-03-07 MX MX2018010788A patent/MX382534B/es unknown
- 2017-03-07 ES ES17709641T patent/ES2922821T3/es active Active
- 2017-03-07 RU RU2018130713A patent/RU2749723C2/ru active
- 2017-03-07 JP JP2018547451A patent/JP2019511494A/ja not_active Revoked
- 2017-03-07 BR BR112018067995-0A patent/BR112018067995B1/pt active IP Right Grant
- 2017-03-07 LT LTEPPCT/EP2017/055338T patent/LT3426226T/lt unknown
- 2017-03-07 EP EP17709641.9A patent/EP3426226B1/de not_active Revoked
- 2017-03-07 PT PT177096419T patent/PT3426226T/pt unknown
- 2017-03-07 WO PCT/EP2017/055338 patent/WO2017153415A1/de not_active Ceased
- 2017-03-07 CN CN201780015735.3A patent/CN108778250A/zh active Pending
- 2017-03-07 KR KR1020187025990A patent/KR20180117635A/ko not_active Ceased
- 2017-03-07 AU AU2017231697A patent/AU2017231697B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0671161B1 (de) | 1993-12-14 | 2003-10-22 | MERCK PATENT GmbH | Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten |
| EP2214658B1 (de) | 2007-10-31 | 2011-06-22 | Bitop AG | Osmolythaltige zubereitung zur anwendung bei trockenen schleimhäuten |
| DE102014007423A1 (de) * | 2014-05-22 | 2015-11-26 | Bitop Ag | Zusammensetzung zur Behandlung des Auges |
Non-Patent Citations (2)
| Title |
|---|
| Patienteninformation zu Collypan(R) Trockene Augen. 2015. URL: https://www.compendium.ch/mpub/pnr/1280792/html/de [abgerufen am 27.10.2016] * |
| Ursapharm Arzneimittel GmbH (Hrsg.): Gebrauchsanweisung Hylo(R)-Protect. 2013 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3426226B1 (de) | 2016-03-07 | 2022-05-04 | URSAPHARM Arzneimittel GmbH | Ophthalmologische zusammensetzung |
Also Published As
| Publication number | Publication date |
|---|---|
| US20190099441A1 (en) | 2019-04-04 |
| RU2749723C2 (ru) | 2021-06-16 |
| CA3015592A1 (en) | 2017-09-14 |
| KR20180117635A (ko) | 2018-10-29 |
| PT3426226T (pt) | 2022-07-20 |
| AU2017231697A1 (en) | 2018-09-13 |
| MX2018010788A (es) | 2019-01-14 |
| ES2922821T3 (es) | 2022-09-20 |
| LT3426226T (lt) | 2022-07-25 |
| RU2018130713A (ru) | 2020-04-08 |
| JP2019511494A (ja) | 2019-04-25 |
| MX382534B (es) | 2025-03-13 |
| EP3426226A1 (de) | 2019-01-16 |
| BR112018067995B1 (pt) | 2023-09-26 |
| BR112018067995A2 (pt) | 2019-01-15 |
| RU2018130713A3 (es) | 2020-06-30 |
| WO2017153415A1 (de) | 2017-09-14 |
| AU2017231697B2 (en) | 2022-07-07 |
| EP3426226B1 (de) | 2022-05-04 |
| CN108778250A (zh) | 2018-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE102016203696A1 (de) | Ophthalmologische Zusammensetzung | |
| DE602004013420T2 (de) | Wässrige flüssige zubereitung mit 2-amino-3-(4-bromobenzoyl)phenylessigsäure | |
| DE60126321T2 (de) | Gelsystem zur ocularen verabreichung von arzneimitteln | |
| DE2649095C2 (es) | ||
| DE60117009T2 (de) | Verwendung einer wässrigen Lösung zur Behandlung von Trockenaugen | |
| EP1455803B2 (de) | Verwendung von panthenol und/oder panthothensäure und hyaluronsäure/und oder hyaluronat zur herstellung einer pharmazeutischen zusammensetzung zur ophtalmologischen anwendung | |
| DE69513902T2 (de) | Augenpräparat zur Verwendung in künstlicher Tränenflüssigkeit | |
| DE69232885T2 (de) | Wässrige Desinfizierungslösung für weiche Kontaktlinsen, Verfahren zur Desinfizierung weicher Kontaklinsen, und preservierte Lösung opthalmischer Arzneimittel | |
| DE69329767T2 (de) | Mukoadhäsive Polymeren | |
| EP0801948B1 (de) | Ophtalmische Zusammensetzung mit verlängerter Verweilzeit am Auge | |
| DE102014116903A1 (de) | Cineolhaltige Zusammensetzung für die nasale Applikation | |
| DE202009019116U1 (de) | Wässrige pharmazeutische Zusammensetzungen, die Borat-Polyol-Komplexe enthalten | |
| EP2766008B1 (de) | Zusammensetzung für die nasale applikation mit verbesserter stabilität | |
| DE102009021372A1 (de) | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung | |
| CH685099A5 (de) | Pharmazeutisches Präparat für die intranasale Anwendung. | |
| EP1453523A1 (de) | Heparin-haltiges ophthalmikum | |
| DE102014007423A1 (de) | Zusammensetzung zur Behandlung des Auges | |
| DE60205913T2 (de) | Ophthalmische zubereitung mit n-acetylcystein zur behandlung trockener augen | |
| DE69828451T2 (de) | Wässrige ophthalmische formulierungen mit chitosan | |
| DE69819900T2 (de) | Wässrige flüssige pharmazeutische zusammensetzung enthaltend ein benzopyranderivat als hauptbestandteil | |
| DE202017104738U1 (de) | Neue Zusammensetzung für die nasale Applikation | |
| DE102009049504A1 (de) | Wund- und Schleimhautantiseptikum auf der Basis von Bispyridiniumalkanen | |
| DE60119337T2 (de) | Aseptische mittel | |
| DE2714676C2 (de) | Augentropfenlösung | |
| DE69613803T2 (de) | Augentropfen insbesonders zur Behandlung des trockenen Auges |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R012 | Request for examination validly filed | ||
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |